Norchem Pharma

Hunan Norchem Pharmaceutical Co., Ltd_Hunan Norchem Pharmaceutical Co., Ltd

Changsha, China · Founded 2013

Headquarters
Changsha
Employees
1001–5000
Founded
2013
Business Model
B2B
Last Round
Series BDec 2023
Rounds
2

About

Hunan Norchem Pharmaceutical Co., Ltd. (Norchem) is a Chinese high-tech pharmaceutical enterprise established in 2013, specializing in the research, development, and manufacturing of steroidal drug intermediates and active pharmaceutical ingredients (APIs) using phytosterols as starting materials. Headquartered in Hunan Province, China with operations spanning Beijing, Shanghai, Zhejiang, and Jiangxi, the company has grown into a group with more than 10 subsidiaries and over 1,500 employees. Norchem is recognized as the first enterprise in China to prepare steroidal drug intermediates and APIs from phytosterol starting materials at commercial scale, and has developed a complete industrial chain encompassing R&D, production, and distribution. The company's products are sold in both domestic and international markets, and Norchem has become one of the largest manufacturers in the global steroid drug sector. The company is actively pursuing IPO readiness and investing in synthetic biology manufacturing to build a comprehensive bio-manufacturing industry chain.

Summary

Norchem Pharma is a Biotech company based in Changsha, China, founded in 2013. Its most recent funding was a Series B round in Dec 2023. Investors include OrbiMed.

Tech & App Stack

1 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series BSeries BDec 2023

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies